This is filed to report atrial flutter requiring intervention.This research article was a prospective study designed to evaluate the use of transcatheter edge-to edge repair (teer) as a safer and effective alternative to surgery in high risk patients with systemic tricuspid regurgitation (str).Complications identified in the study included positioning failure, off label use, atrial perforation, atrial flutter and unexpected medical intervention.In conclusion, percutaneous teer for str appears to be feasible, safe, and effective.Details are listed in the attached article "percutaneous edge-to-edge tricuspid repair in patients with systemic right ventricle".
|
The products were not returned for analysis.The lot history record (lhr) review and similar complaint review were not performed because this complaint was based on a review article, and no device/lot information was provided.Based on the limited information provided, a cause for the reported positioning failure could not be determined.It should be noted that the mitraclip g4 system instructions for use states under the "1.0 intended use" section that "the mitraclip g4 system is intended for reconstruction of the insufficient mitral valve through tissue approximation.¿ the reported off-label use was due to the user performing the mitraclip procedure on the tricuspid valve.Atrial flutter is listed in the instructions for use as a known possible complication associated with mitraclip procedures.A cause for atrial flutter could not be determined.The reported unexpected medical intervention was a result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design, or labeling.
|